Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Johnson & Johnson's quarterly finished goods
declined
from Dec. 2025 (COP29,299,023 Mil) to Mar. 2026 (COP29,174,052 Mil) and
declined
from Mar. 2026 (COP29,174,052 Mil) to Jun. 2026 (COP28,940,515 Mil).
Johnson & Johnson's annual finished goods
increased
from Dec. 2023 (COP27,532,640 Mil) to Dec. 2024 (COP32,331,853 Mil) but then
declined
from Dec. 2024 (COP32,331,853 Mil) to Dec. 2025 (COP29,299,023 Mil).
Johnson & Johnson Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Johnson & Johnson's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson & Johnson Inventories, Finished Goods Chart
What does a Inventories, Finished Goods of COP28,940,515 Mil mean?
Johnson & Johnson (BOG:JNJCO) has a Inventories, Finished Goods of COP28,940,515 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Inventories, Finished Goods too high?
Johnson & Johnson's current Inventories, Finished Goods is COP28,940,515 Mil. Overall, Johnson & Johnson has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Inventories, Finished Goods compare to ABBV and MRK?
Johnson & Johnson's Inventories, Finished Goods of COP28,940,515 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Inventories, Finished Goods is COP28,940,515 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Johnson & Johnson (BOG:JNJCO) has a current Inventories, Finished Goods of COP28,940,515 Mil. The stock's GF Value™ is COP610,953.69, compared to a current price of COP824,700.00 — trading 35% above its estimated fair value. The current Inventories, Finished Goods is COP28,940,515 Mil. Johnson & Johnson's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Johnson & Johnson (BOG:JNJCO), the current Inventories, Finished Goods is COP28,940,515 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Johnson & Johnson (BOG:JNJCO) Overvalued in 2026?
Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued.
The current stock price of COP824,700.00 is trading 35% above its estimated GF Value™ of COP610,953.69.
Key valuation signals for BOG:JNJCO:
Inventories, Finished Goods: COP28,940,515 Mil
GF Value™: COP610,953.69 vs. price of COP824,700.00 (35% above fair value)
No single metric tells the full story. See the BOG:JNJCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
72GF Score
Get the complete analysis for BOG:JNJCO
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOG:JNJCO has been successfully added to your 
